A recent report from BIO details challenges in the antibiotic market — and new policy measures that could help.

Next to serious health threats like cancer or dementia, skin and urinary tract infections might seem run-of-the-mill. But antibiotic-resistant infections are a rising threat, killing about 1.2 million people worldwide each year.

A recent industry report from the Biotechnology Innovation Organization (BIO) trade association is sounding the alarm: Unless policy changes encourage more antibacterial drug development, the number of global deaths caused by antibiotic-resistant bugs could grow to an estimated 10 million a year by 2050…

Read the full piece at PharmaVoice here.